Latest stories on FBLG
FibroBiologics announces USPTO issued patent on use of fibroblasts
The Fly63 · neutralproduct/pr
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
PR Newswire59 · neutralproduct/pr
FibroBiologics announces USPTO issued patent for Fibroblast Conditioned Media
The Fly63 · neutralproduct/pr
FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
PR Newswire63 · neutralproduct/pr
FibroBiologics Regains Compliance with Nasdaq Trading Rules
PR Newswire55 · neutralgeneral
FibroBiologics Adds Leigh Steinberg to Board for Growth
TipRanks56 · neutralgeneral
FibroBiologics, Inc. (FBLG) files 8-K
SEC 8-K50 · neutralgeneral
FibroBiologics Appoints Leigh Steinberg to Board of Directors
PR Newswire55 · neutralgeneral
FibroBiologics says Australian patent accepted for Cannabidiol Adjuvant Therapy
The Fly63 · neutralgeneral
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease
PR Newswire59 · neutralproduct/pr
FibroBiologics announces laboratory findings in joint cartilage repair
The Fly59 · neutralproduct/pr
FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints
PR Newswire63 · neutralproduct/pr
FibroBiologics awarded new patent from USPTO
The Fly65 · bullishgeneral
FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage
PR Newswire63 · neutralproduct/pr
H.C. Wainwright cuts FibroBiologics price target to $6 on model adjustments
Investing.com Analyst Ratings34 · bearishanalyst
FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
PR Newswire56 · neutralearnings
FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
StockTitan56 · neutralproduct/pr
FibroBiologics, Inc. (FBLG) files 8-K
SEC 8-K34 · bearishgeneral
FibroBiologics Appoints NASA Scientist Kate Rubins to Board
TipRanks58 · neutralgeneral
FibroBiologics, Inc. (FBLG) files 8-K
SEC 8-K50 · neutralgeneral
FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors
PR Newswire55 · neutralgeneral
FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors | FBLG Stock News
StockTitan63 · neutralgeneral